Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19 | Zendy

Farzaneh Dastan | Zendy; Ali Saffaei | Zendy; Seyed Mehdi Mortazavi | Zendy; Hamidreza Jamaati | Zendy; Nadia Adnani | Zendy; Sasan Samiee Roudi | Zendy; Arda Kiani | Zendy; Atefeh Abedini | Zendy; Seyed Mohammad Reza Hashemian | Zendy

Open Access

Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19

Author(s) -

Farzaneh Dastan,

Ali Saffaei,

Seyed Mehdi Mortazavi,

Hamidreza Jamaati,

Nadia Adnani,

Sasan Samiee Roudi,

Arda Kiani,

Atefeh Abedini,

Seyed Mohammad Reza Hashemian

Publication year - 2020

Publication title -

journal of global antimicrobial resistance

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.917

H-Index - 26

eISSN - 2213-7173

pISSN - 2213-7165

DOI - 10.1016/j.jgar.2020.04.024

Subject(s) - hemoperfusion , extracorporeal , medicine , covid-19 , renal replacement therapy , intensive care medicine , extracorporeal membrane oxygenation , surgery , hemodialysis , virology , disease , infectious disease (medical specialty) , outbreak

Cytokine release syndrome is prevalent in severe cases of COVID-19. In this syndrome, an uncontrolled response of immune system occurs. Extracorporeal blood purification has been proven to effectively remove the released inflammatory cytokines. Here, we reported a successful case to represent our experience of extracorporeal blood purification in a patient with severe COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research